Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation
Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A. Bone Marrow Transplant. 2004; 33(5):509-17.
Publications
Changes in prescribing patterns following publication of the ALLHAT trial
Austin PC, Mamdani MM, Tu K, Zwarenstein M. JAMA. 2004; 291(1):44-5.
Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000
Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2004; 20(1):61-7.
Parkinsonism in Ontario: comorbidity associated with hospitalization in a large cohort
Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Mov Disord. 2004; 19(1):49-53.
Avoiding drug interactions in hospitalized patients
Juurlink D, Mamdani M, Iazzetta J, Etchells E. Healthc Q. 2004; 7(2):27-8.
Prostate-specific antigen screening in elderly men
Lu-Yao G, Stukel TA, Yao SL. J Natl Cancer Inst. 2003; 95(23):1792-7.
Impact of socioeconomic status on cardiovascular outcomes in Canada
Alter DA, Brandes S, Irvine J, Iron K. Expert Rev Pharmacoecon Outcomes Res. 2003; 3(6):691-702.
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model
Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. JAMA. 2003; 290(19):2581-7.
Canadian cardiovascular hospitalization rates and length of stay
Hall R. Healthc Q. 2003; 7(1):22-4.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(12):1359-66.